Search

everythinglearnresearchcommunity

for

Search:↓

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Infliximab may cause hair loss in Crohn's disease patients.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

DM and AA may share a common cause.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Identical twins had different symptoms because one had more cells with an extra chromosome fragment in different tissues.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Blocking mTORC1 reduces skin tumor growth in mice.

Reducing CD8+ T cell growth can stabilize alopecia areata.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Tofacitinib treatment is used for teenagers with alopecia areata.

The study identified key immune cell differences between mild and severe alopecia areata.

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

Trichodysplasia spinulosa is a rare skin disease in immunocompromised patients caused by a specific virus targeting hair follicle cells.

A targetoid hair regrowth pattern indicates recovery in alopecia areata.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Calancardin B may help reduce inflammation in immune cells.